Oncternal Therapeutics, Inc.

ONCT · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$6,697$37,142$90,765$116,737
Short-Term Investments$27,558$26,582$0$0
Receivables$632$178$944$0
Inventory$0$103$0$0
Other Curr. Assets$1,172$3,388$1,503$1,266
Total Curr. Assets$36,059$67,290$92,853$118,003
Property Plant & Equip (Net)$258$87$75$40
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$412$1,274$657$766
Total NC Assets$670$1,361$732$806
Other Assets$0$0$0$0
Total Assets$36,729$68,651$93,585$118,809
Liabilities
Payables$1,148$2,917$1,959$1,143
Short-Term Debt$173$87$75$40
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$1,633
Other Curr. Liab.$3,877$4,678$3,431$3,042
Total Curr. Liab.$5,198$7,682$5,465$5,858
LT Debt$145$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,334$0$0$0
Total NC Liab.$1,479$3,004$0$0
Other Liabilities$0-$3,004$0$0
Cap. Leases$318$87$75$40
Total Liabilities$6,677$7,682$5,465$5,858
Equity
Pref Stock$0$0$0$0
Common Stock$3$57$49$49
Retained Earnings-$197,779-$158,300-$114,130-$82,797
AOCI$3$9$0-$0
Other Equity$227,825$219,203$202,201$195,699
Total Equity$30,052-$158,300-$114,130-$82,797
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$36,729$68,651-$108,665-$76,939
Net Debt-$6,379-$37,055-$90,690-$116,697
Oncternal Therapeutics, Inc. (ONCT) Financial Statements & Key Stats | AlphaPilot